awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q49963693-F766C421-0211-4E1E-A461-5E65404342D4
Q49963693-F766C421-0211-4E1E-A461-5E65404342D4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49963693-F766C421-0211-4E1E-A461-5E65404342D4
Dapagliflozin Reduces Fat Mass without Affecting Muscle Mass in Type 2 Diabetes.
P2860
Q49963693-F766C421-0211-4E1E-A461-5E65404342D4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49963693-F766C421-0211-4E1E-A461-5E65404342D4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c6c31ceed23d05f4b18effe3e79cc01e615150f2
P2860
Dapagliflozin compared with other oral anti-diabetes treatments when added to metformin monotherapy: a systematic review and network meta-analysis.